Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (6)

2024

  1. Correction to: Biosafety evaluation of etoposide lipid nanomedicines in C. elegans (Drug Delivery and Translational Research, (2024), 10.1007/s13346-023-01466-w)

    Drug Delivery and Translational Research

2023

  1. Lipid nanoparticles for siRNA delivery in cancer treatment

    Journal of Controlled Release, Vol. 361, pp. 130-146

2022

  1. In vivo biodistribution of edelfosine-loaded lipid nanoparticles radiolabeled with Technetium-99 m: Comparison of administration routes in mice

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 175, pp. 1-6

  2. Nanomedicines and cell-based therapies for embryonal tumors of the nervous system

    Journal of Controlled Release, Vol. 348, pp. 553-571

2021

  1. Oral lipid nanomedicines: Current status and future perspectives in cancer treatment

    Advanced Drug Delivery Reviews, Vol. 173, pp. 238-251

  2. Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma

    International Journal of Pharmaceutics, Vol. 608